-
McNeil Consumer recalls one lot of Imodium on wholesale level due to damaged package
FORT WASHINGTON, Pa. — McNeil Consumer Healthcare on Thursday informed its wholesale customers that it is voluntarily recalling one lot of Imodium multi-symptom relief 18 caplets due to a packaging issue that may have impacted a limited number of blister units in this lot.
The product is being recalled at the wholesale level only, and not from consumers or from store shelves, as there are no safety concerns or adverse events related to the reason for the recall. The lot number (CMF023) for the recalled product can be found on the side of the product box.
-
FDA approves generic Parkinson's disease drug made by Actavis
MORRISTOWN, N.J. — The Food and Drug Administration has approved a treatment for Parkinson's disease made by Actavis, the drug maker said Friday.
Actavis, which last month signed a deal with Watson Pharmaceuticals to be acquired for $5.6 billion, announced the approval and launch of ropinirole extended-release tablets in the 2-mg, 4-mg, 6-mg, 8-mg and 12-mg strengths.
The drug is a generic version of GlaxoSmithKline's Requip XL, which had sales of about $59.4 million in 2011, according to IMS Health.